ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
2022年02月28日 17時00分
Source:
NEC Corporation
NEC、代表取締役およびその他の役員の異動について
東京, 2022年02月28日 - (JCN Newswire) - 当社は、本日開催の取締役会において、2022年6月開催予定の定時株主総会日付の役員人事を内定いたしましたので、お知らせいたします。
1.代表取締役の異動(2022年6月定時株主総会日付) ( )内は現職
(1)新任代表取締役
代表取締役 執行役員常務 兼 CFO 藤川 修 (執行役員常務 兼 CFO)
※CFO:チーフフィナンシャルオフィサー
(2)退任代表取締役
取締役会長 新野 隆 (代表取締役副会長)
(3)異動の理由
経営体制の変更のため。
(4)新任代表取締役の略歴
氏名:藤川 修(ふじかわ おさむ)
生年月日:1965年5月18日
略歴
1988年4月 当社入社
2014年4月 事業イノベーション戦略本部長
2017年4月 執行役員
2021年4月 執行役員常務 兼 CFO(チーフフィナンシャルオフィサー)、現在に至る。
所有株式数:1,500株
本リリースの詳細は下記をご参照ください。
https://jpn.nec.com/press/202202/20220228_02.html
概要:日本電気株式会社(NEC)
詳細は www.nec.co.jp をご覧ください。
Source: NEC Corporation
セクター: 金融, IT
Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
MHI Receives Order for Additional 12 Units of the Outer Vertical Target for the Divertor Used in the ITER in Southern France
May 20, 2024 11:36 JST
Fujitsu chosen for GENIAC project, starts development of large language models for logical reasoning
May 17, 2024 14:03 JST
NEC Leverages RISE with SAP and AI to Build Business AI in Move to the Cloud
May 17, 2024 11:19 JST
Honda and IBM sign Memorandum of Understanding to Explore Long-term Joint Research and Development of Semiconductor Chip and Software Technologies for Future Software-Defined Vehicles
May 15, 2024 14:30 JST
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status
May 15, 2024 11:19 JST
SMEIC Proposes to Acquire Shanghai Prime: A Catalyst for Developing a New Dual-Wheel Driver Pattern
May 14, 2024 21:54 JST
DENSO and Certhon Introduce Artemy, A Fully Automated Cherry Truss Tomato Harvesting Robot
May 14, 2024 11:02 JST
Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings
May 13, 2024 18:32 JST
Eisai's Antiepileptic Drug Fycompa Approved in China for Adjunctive Treatment of Primary Generalized Tonic-Clonic Seizures
May 13, 2024 17:06 JST
Ogier and TOYOTA GAZOO Racing triumph again
May 13, 2024 14:36 JST
Spa points haul for TOYOTA GAZOO Racing
May 13, 2024 13:56 JST
DOCOMO to Launch NTT DOCOMO GLOBAL for Global Expansion
May 10, 2024 18:13 JST
Release of "Fugaku-LLM" - a large language model trained on the supercomputer "Fugaku"
May 10, 2024 12:20 JST
Paltalk, Inc. Reports Slight Increase in Revenue and 33% Reduction in Net Loss for First Quarter 2024
May 09, 2024 20:39 JST
Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
May 09, 2024 19:00 JST
Honda Opens New R&D Facility in Bengaluru to Accelerate Electrification in India
May 09, 2024 14:13 JST
Fujitsu introduces "explainable AI" for use in genomic medicine and cancer treatment planning
May 09, 2024 10:41 JST
Mitsubishi Heavy Industries Increases Dividends on Back of Historically High FY2023 Results, Releases FY2024 Guidance
May 08, 2024 14:27 JST
Rome becomes the first European city to offer open loop transit payments to JCB Cardmembers
May 08, 2024 12:00 JST
NEC X Invests in Public Safety Startup Multitude Insights, Scaling AI-Powered Collaboration and Information Sharing for Law Enforcement
May 08, 2024 10:24 JST
More Latest Release >>
Related Release
NEC Leverages RISE with SAP and AI to Build Business AI in Move to the Cloud
5/17/2024 11:19:00 AM JST
NEC X Invests in Public Safety Startup Multitude Insights, Scaling AI-Powered Collaboration and Information Sharing for Law Enforcement
5/8/2024 10:24:00 AM JST
NEC Develops High-speed Generative AI Large Language Models (LLM) with World-class Performance
4/24/2024 1:25:00 PM JST
NEC Strengthens Commitment to Space Industry with Investment in Seraphim Space Venture Fund II
4/22/2024 3:09:00 PM JST
DOCOMO, NTT, NEC and Fujitsu Develop Top-level Sub-terahertz 6G Device Capable of Ultra-high-speed 100 Gbps Transmission
4/11/2024 3:10:00 PM JST
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
4/10/2024 1:36:00 PM JST
NEC white paper proposes comprehensive process workflow for the application of AI-driven personalized cancer vaccines
4/8/2024 1:45:00 PM JST
NEC develops marketing strategy planning & effectiveness simulation technology using generative AI
3/25/2024 10:08:00 AM JST
NEC and NTT successfully conduct first-of-its-kind long-distance transmission experiment over 7,000km using 12-core optical fiber
3/22/2024 8:38:00 AM JST
NEC and Tokyo Medical and Dental University use AI to assist self-care for chronic lower back pain
3/21/2024 10:02:00 AM JST
More Press release >>